Figure 1:
MEN1 mutations in cancers
Aggregation of singular studies and TCGA analyses demonstrates that MEN1 mutations are relatively infrequent in cancers with the exception of pancreatic neuroendocrine tumors and parathyroid adenomas (cbiportal.org).